A Biomarker-Centric Diagnostic Approach based on Neutrophil Percentage to Albumin Ratio (NPAR) for Diabetic UTIs: Biomarker-Centric Diagnostic Approach for Diabetic Urinary Tract Infections

Abdul Samad; Shahid Zafar; Mostafa Ahmed Abdellah Ahmed; Naveed Ahsan; Muhammad Rizwan; Shahid Pervez Shaikh; Muhammad Arsalan Shah

doi:10.54393/pjhs.v5i11.2534

Authors

Abdul Samad Department of Urology, Isra University, Hyderabad, Pakistan
Shahid Zafar Department of Pathology, Liaquat College of Medicine and Dentistry, Karachi, Pakistan
Mostafa Ahmed Abdellah Ahmed Department of General Surgery, Cairo University, Cairo, Egypt
Naveed Ahsan Department of Biochemistry, Bhitai Dental and Medical College, Mirpurkhas, Pakistan
Muhammad Rizwan Department of Hematology, Baqai Institute of Hematology, Baqai Medical University, Karachi, Pakistan
Shahid Pervez Shaikh Department of Anatomy, Baqai Medical University, Karachi, Pakistan
Muhammad Arsalan Shah Department of Pathology, University of health Sciences, Lahore, Pakistan

DOI:

https://doi.org/10.54393/pjhs.v5i11.2534

Keywords:

Neutrophil Percentage to Albumin Ratio, Diabetic Urinary Tract Infection, Inflammation Biomarkers, Hypoalbuminemia, Renal Complications

Abstract

The Neutrophil Percentage to Albumin Ratio (NPAR) was identified as a promising biomarker for identifying inflammation and renal complications in diabetic Urinary Tract Infections (UTIs). Objective: To evaluate the diagnostic potential of NPAR as a novel biomarker for the diagnosis and prognosis of diabetic UTIs. Methods: The current study was carried out according to PRISMA criteria to determine the prognostic value of the Neutrophil Percentage to Albumin Ratio (NPAR) in diabetic UTIs. The study (April 2024 to June 2024) was made on Google Scholar, Science Direct, PubMed with a date ranging from 2014 to 2024. Articles comparing NPAR effect on non-diabetic and diabetic UTI-related inflammation, immune cells suppression, comparison of NPAR to classic biomarkers with comorbidities and renal damage were taken for the review. Information was available from different world areas, such as the Asia Pacific, Europe, and the America’s for breadth. The first search found 162 papers, but 134 remained after duplicates were deleted, and these were screened and reviewed, resulting in the inclusion of 15 studies in the systematic review. Results: The findings of the study demonstrated that NPAR has higher reliability in diagnosing inflammation and prognosis than traditional biomarkers, especially in septic patients with hypoalbuminemia. Conclusions: Due to the reliability, sensitivity and specificity of NPAR, it was a potential biomarker for evaluating inflammation and prognosis of patients with diabetic UTI. Its implementation as part of clinical practice could extend understanding on disorder and early identification.

References

Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas. Diabetes research and clinical practice. 2019 Nov 1;157:107843. doi:10.1016/j.diabres.2019.107843

Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease: challenges, progress, and possibilities. Clinical Journal of the American Society of Nephrology. 2017 Dec; 12(12): 2032-45. doi: 10.2215/CJN.11491116.

Młynarska E, Buławska D, Czarnik W, Hajdys J, Majchrowicz G, Prusinowski F et al. Novel Insights into Diabetic Kidney Disease. International Journal of Molecular Sciences. 2024 Sep; 25(18): 10222. doi: 10.3390/ijms251810222.

Daryabor G, Atashzar MR, Kabelitz D, Meri S, Kalantar K. The effects of type 2 diabetes mellitus on organ metabolism and the immune system. Frontiers in Immunology. 2020 Jul; 11: 1582. doi: 10.3389/fimmu.2020.01582.

Fekete T. Catheter-associated urinary tract infection in adults. UpToDate. March. 2020 Mar; 7; 117(6): 83–88. doi: 10.3238/arztebl.2020.0083.

Kama SC, Obeagu EI, Alo MN, Ochei KC, Ezugwu UM, Odo M et al. Incidence of Urinary Tract Infection among Diabetic Patients in Abakaliki Metropolis. Journal of Pharmaceutical Research International. 2020 Nov; 32(28): 117-21. doi: 10.9734/jpri/2020/v32i2830878.

Tullus K and Shaikh N. Urinary tract infections in children. The Lancet. 2020 May; 395(10237): 1659-68. doi: 10.1016/S0140-6736(20)30676-0.

Jaaban M, Zetoune AB, Hesenow S, Hessenow R. Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as novel risk markers for diabetic nephropathy in patients with type 2 diabetes. Heliyon. 2021 Jul; 7(7). doi: 10.1016/j.heliyon.2021.e07564.

Chen J, Zhang D, Zhou D, Dai Z, Wang J. Association between red cell distribution width/serum albumin ratio and diabetic kidney disease. Journal of Diabetes. 2024 Jul; 16(7): e13575. doi: 10.1111/1753-0407.13575.

Donate-Correa J, Luis-Rodríguez D, Martín-Núñez E, Tagua VG, Hernández-Carballo C, Ferri C et al. Inflammatory targets in diabetic nephropathy. Journal of Clinical Medicine. 2020 Feb; 9(2): 458. doi: 10.3390/jcm9020458.

Andreotti F, Maggioni AP, Campeggi A, Iervolino A, Scambia G, Massetti M. Anti-inflammatory therapy in ischaemic heart disease: from canakinumab to colchicine. European Heart Journal Supplements. 2021 Oct; 23(Supplement_E): E13-8. doi: 10.1093/eurheartj/suab084.

Chen S, Chen L, Jiang H. Prognosis and risk factors of chronic kidney disease progression in patients with diabetic kidney disease and non-diabetic kidney disease: a prospective cohort CKD-ROUTE study. Renal Failure. 2022 Dec; 44(1): 1310-9. doi: 10.1080/0886022X.2022.2106872.

Samsu N. Diabetic nephropathy: challenges in pathogenesis, diagnosis, and treatment. BioMed Research International. 2021 Jul; 2021: 1497449. doi: 10.1155/2021/1497449.

Quang TH, Nguyet MP, Thao DP, Thi MH, Phuong Thi Dam L et al. Evaluation of urinary neutrophil gelatinase associated lipocalin and kidney injury molecule-1 as diagnostic markers for early nephropathy in patients with type 2 diabetes mellitus. Diabetes, Metabolic Syndrome and Obesity. 2020 Jun: 2199-207. doi: 10.2147/DMSO.S258678.

Subramani M, Anbarasan M, Shanmugam D, Muthumani LN, Vasudevan P. Role of neutrophil-lymphocyte ratio as a prognostic marker for type 2 diabetic nephropathy among Indians. Bioinformation. 2023 Apr; 19(4): 375. doi: 10.6026/97320630019375.

Kahraman C, Kahraman NK, Aras B, Coşgun S, Gülcan E. The relationship between neutrophil-to-lymphocyte ratio and albuminuria in type 2 diabetic patients: a pilot study. Archives of Medical Science. 2016 May; 12(3): 571-5. doi: 10.5114/aoms.2016.59931.

Wang B, Li D, Cheng B, Ying B, Gong Y. The neutrophil percentage‐to‐albumin ratio is associated with all‐cause mortality in critically ill patients with acute kidney injury. BioMed Research International. 2020 Feb; 2020(1): 5687672. doi: 10.1155/2020/5687672.

Jing Y, Tian B, Deng W, Ren Z, Xu X, Zhang D et al. The Neutrophil Percentage‐to‐Albumin Ratio as a Biomarker for All‐Cause and Diabetes‐Cause Mortality among Diabetes Patients: Evidence from the NHANES 1988-2018. Journal of Clinical Laboratory Analysis. 2024 Oct: e25110. doi: 10.1002/jcla.25110.

Winter L, Wong LA, Jerums G, Seah JM, Clarke M, Tan SM et al. Use of readily accessible inflammatory markers to predict diabetic kidney disease. Frontiers in Endocrinology. 2018 May; 9: 225. doi: 10.3389/fendo.2018.00225.

Yang Y, Tan J, He Y, Huang H, Wang T, Gong J et al. Predictive model for diabetic retinopathy under limited medical resources: A multicenter diagnostic study. Frontiers in Endocrinology. 2023 Jan; 13: 1099302. doi: 10.3389/fendo.2022.1099302.

Xu S, Wang Y, Hu Z, Ma L, Zhang F, Liu P. Effects of neutrophil‐to‐lymphocyte ratio, serum calcium, and serum albumin on prognosis in patients with diabetic foot. International Wound Journal. 2023 May; 20(5): 1638-46. doi: 10.1111/iwj.14019.

He X, Dai F, Zhang X, Pan J. The neutrophil percentage‐to‐albumin ratio is related to the occurrence of diabetic retinopathy. Journal of Clinical Laboratory Analysis. 2022 Apr; 36(4): e24334. doi: 10.1002/jcla.24334.

Li J, Xiang T, Chen X, Fu P. Neutrophil-percentage-to-albumin ratio is associated with chronic kidney disease: Evidence from NHANES 2009-2018. PLOS One. 2024 Aug; 19(8): e0307466. doi: 10.1371/journal.pone.0307466.

Benitez-Aguirre PZ, Marcovecchio ML, Chiesa ST, Craig ME, Wong TY, Davis EA et al. Urinary albumin/creatinine ratio tertiles predict risk of diabetic retinopathy progression: a natural history study from the Adolescent Cardio-Renal Intervention Trial (AdDIT) observational cohort. Diabetologia. 2022 May; 65(5): 872-8. doi: 10.1007/s00125-022-05661-1.

Tan J, Zhang Z, He Y, Yu Y, Zheng J, Liu Y et al. A novel model for predicting prolonged stay of patients with type-2 diabetes mellitus: a 13-year (2010-2022) multicenter retrospective case-control study. Journal of Translational Medicine. 2023 Feb; 21(1): 91. doi: 10.1186/s12967-023-03959-1.

Khandare SA, Chittawar S, Nahar N, Dubey TN, Qureshi Z. Study of neutrophil-lymphocyte ratio as novel marker for diabetic nephropathy in type 2 diabetes. Indian Journal of Endocrinology and Metabolism. 2017 May; 21(3): 387-92. doi: 10.4103/ijem.IJEM_476_16.

Malhotra R, Katz R, Jotwani V, Ambrosius WT, Raphael KL, Haley W et al. Urine markers of kidney tubule cell injury and kidney function decline in SPRINT trial participants with CKD. Clinical Journal of the American Society of Nephrology. 2020 Mar; 15(3): 349-58. doi: 10.2215/CJN.02780319.

Wang Y, Peng X, Hu J, Luo T, Wang Z, Cheng Q et al. Low‐dose colchicine in type 2 diabetes with microalbuminuria: A double‐blind randomized clinical trial. Journal of Diabetes. 2021 Oct; 13(10): 827-36. doi: 10.1111/1753-0407.13174.

Ahmad S, Hussain A, Khan MS, Shakireen N, Ali I. Diabetes mellitus and urinary tract infection: Causative uropathogens, their antibiotic susceptibility pattern and the effects of glycemic status. Pakistan Journal of Medical Sciences. 2020 Nov; 36(7): 1550. doi: 10.12669/pjms.36.7.2881.

Confederat LG, Condurache MI, Alexa RE, Dragostin OM. Particularities of urinary tract infections in diabetic patients: a concise review. Medicina. 2023 Sep 29;59(10):1747. doi:10.3390/medicina59101747

Nabi T. Clinical profile and risk factors of recurrent urinary tract infection in patients with type 2 diabetes. International Journal of Academic Medicine. 2020 Oct 1;6(4):301-8. doi: 10.4103/IJAM.IJAM_83_20

Wyndaele M, Charrua A, Hervé F, Aronsson P, Grundy L, Khullar V et al. Beyond the urothelium: Interplay between autonomic nervous system and bladder inflammation in urinary tract infection, bladder pain syndrome with interstitial cystitis and neurogenic lower urinary tract dysfunction in spinal cord injury-ICI‐RS 2023. Neurourology and Urodynamics. 2024 Aug; 43(6): 1283-92. doi: 10.1002/nau.25310.

Minici R, Siciliano MA, Ammendola M, Santoro RC, Barbieri V, Ranieri G et al. Prognostic role of Neutrophil-To-Lymphocyte Ratio (NLR), Lymphocyte-To-Monocyte Ratio (LMR), Platelet-To-Lymphocyte Ratio (PLR) and Lymphocyte-To-C Reactive Protein Ratio (LCR) in patients with Hepatocellular Carcinoma (HCC) undergoing chemoembolizations (TACE) of the liver: the unexplored corner linking tumor microenvironment, biomarkers and interventional radiology. Cancers. 2022 Dec; 15(1): 257. doi: 10.3390/cancers15010257.

Zhao S, Liu X, Shaobo SU, Xiaoqing WU. Predictive value of monocyte to lymphocyte ratio, neutrophil percentage to albumin ratio for diabetic macular edema. Journal of Xinxiang Medical College. 2024 Jun 1;41(1):21-5. doi: 10.7683/xxyxyxb.2024.01.004

Wadood M, Memon A, Salman W, Iftikhar A, Raza F, Ahsan N, et al. Comprehensive Insights into the Neutrophil Percentage to Albumin Ratio (NPAR): An Emerging Integrated Biomarker for Inflammation and Prognosis: Neutrophil Percentage to Albumin Ratio: Emerging Integrated Biomarker for Inflammation. Pakistan Journal of Health Sciences. 2024 Oct 31. doi:10.54393/pjhs.v5i10.2401

Gao Y, Han Z, Feng X, Zheng H, Dong J, Zhan X et al. Association of Neutrophil and Albumin With Mortality Risk in Patients Receiving Peritoneal Dialysis. Journal of Renal Nutrition. 2024 May; 34(3): 252-9. doi: 10.1053/j.jrn.2023.10.009.

Rasmussen LJ, Petersen JE, Eugen-Olsen J. Soluble urokinase plasminogen activator receptor (suPAR) as a biomarker of systemic chronic inflammation. Frontiers in Immunology. 2021 Dec; 12: 780641. doi: 10.3389/fimmu.2021.780641.

Woo S, Seo D, Cho YS, Lee JW, Moon J, Nah S et al. Clinical factors distinguishing renal infarction from acute pyelonephritis: A randomly matched retrospective case-control study. The American Journal of Emergency Medicine. 2023 Oct; 72: 88-94. doi: 10.1016/j.ajem.2023.07.036.

Scott MM and Liang SY. Infections in older adults. Emergency Medicine Clinics. 2021 May; 39(2): 379-94. doi: 10.1016/j.emc.2021.01.004.

Barnes HC, Wolff B, Abdul-Rahim O, Harrington A, Hilt EE, Price TK, Halverson T et al. A randomized clinical trial of standard versus expanded cultures to diagnose urinary tract infections in women. The Journal of Urology. 2021 Nov; 206(5): 1212-21. doi: 10.1097/JU.0000000000001949.

Öztürk R and Murt A. Epidemiology of urological infections: a global burden. World Journal of Urology. 2020 Nov; 38: 2669-79. doi: 10.1007/s00345-019-03071-4.